PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Octagon Research Solutions, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Octagon Research Solutions, Inc. Unveils eCTD JumpStart - Octagon Research Solutions, Inc., today unveiled eCTD JumpStart, a new high-value service offering consisting of documentation and services designed to accelerate compliance with electronic regulatory submission regulations worldwide.
Octagon Research Solutions, Inc. Unveils eCTD JumpStart

 

NewswireToday - /newswire/ - Wayne, PA, United States, 2006/06/23 - Octagon Research Solutions, Inc., today unveiled eCTD JumpStart, a new high-value service offering consisting of documentation and services designed to accelerate compliance with electronic regulatory submission regulations worldwide..

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Octagon Research Solutions, Inc., a pioneer and leader in the electronic transformation of clinical R&D to the life sciences industry, today unveiled eCTD JumpStart, a new high-value service offering consisting of documentation and services designed to accelerate compliance with electronic regulatory submission regulations worldwide. Octagon recognized that for many companies, authoring templates alone are not enough. Building on the market leading StartingPoint® eCTD template suite, eCTD JumpStart will help companies move beyond well-formatted documents to creating a solid eCTD foundation.

eCTD JumpStart includes a Style Guide, Document Naming Conventions, a Folder Structure for storing and managing Regulatory Submission Documents, and Bookmarking and Hyperlinking Standards. In addition, it includes consulting services which address how Document Processes can pull together all of these standards to facilitate the efficient creation, management, and retrieval of submission-ready documents. These components have been honed through Octagon’s collective breadth of knowledge and experience from having prepared hundreds of electronic submissions since the company’s inception.

John Lawrie, vice president of Process Solutions at Octagon, noted, “eCTD JumpStart encapsulates the deep domain knowledge and practical experience of some of the industry’s leading experts in electronic submissions. Never before has such a rich resource been made available to the marketplace in a single package. eCTD JumpStart is a stand-alone offering or can be the perfect complement for our StartingPoint template suite, and will provide a strong electronic submission foundation for any company. We believe the consulting services integrated with eCTD JumpStart will be the catalyst many companies are looking for to accelerate the electronic submission learning curve.”

StartingPoint® 2.1, the latest version of Octagon’s market-leading template tool, is being released simultaneously with eCTD JumpStart. Launched in 2003, StartingPoint includes a master template which defines formatting and automation functionality, over 170 authoring templates across all five CTD modules, validation test scripts and a comprehensive user guide. The automated toolbar provides functionality for custom styles, pre-formatted tables, page orientation, frequently used symbol characters, and instructional text regarding content and format.

New for StartingPoint® version 2.1 are a host of new content templates based on Octagon’s extensive regulatory experience. These include a template to support the authoring and submission of Physician Labeling Rule (PLR) labels, a template to support legacy non-PLR labels, as well as Integrated Summaries of Safety (ISS) and Efficacy (ISE) and M3 Quality templates which include boilerplate tables based on Octagon’s extensive submission experience and ICH guidance text.

More information on eCTD JumpStart and StartingPoint® will be on display at the 42nd Annual DIA (Drug Information Association) Meeting on June 18-22nd at the Philadelphia Convention Center booth number 1809.

About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading process-centric solutions provider that offers a suite of regulatory, clinical, process and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional eSub expertise, a holistic process approach, deep domain knowledge and integrated solutions. Octagon is headquartered in Wayne, PA, with offices in Boston, MA, Costa Mesa, CA, and European headquarters in Amersham, UK.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Octagon Research Solutions, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Octagon Research Solutions, Inc. Unveils eCTD JumpStart

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jim Graham 
610 535 6500 / 5655 jgraham[.]octagonresearch.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Octagon Research Solutions, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Octagon Research Solutions, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)